A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

NCT07549581 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Major Depressive Disorder (MDD)
Bipolar Disorder

Interventions

DRUG: SEP-380135
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.